<DOC>
	<DOC>NCT01307124</DOC>
	<brief_summary>To compare the safety and efficacy of low-dose versus standard dose lopinavir/ritonavir containing HAART regimen in virological suppress, HIV RNA viral load &lt; 50 copies/ml at 48 week</brief_summary>
	<brief_title>Pediatric Study for Appropriate Dose of Ritonavir Boosted Lopinavir in Thai HIV-infected Children (PEARL)</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<criteria>1. HIV infection children age &lt; 18 years old 2. Currently on PI regimens 3. HIV RNA viral load &lt; 50 copies/ml at screening 4. BW 2550 kg 5. Written informed consent 1. Relevant history or current condition of PI resistance, plasma HIV RNA &gt; 1000 copies/ml after received the PI regimens for at least 6 months 2. On rifampin, nevirapine, efavirenz which have drug interaction with lopinavir 3. On double boosted protease inhibitors</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>safety and efficacy</keyword>
	<keyword>low dose LPV/r</keyword>
	<keyword>standard dose LPV/r</keyword>
	<keyword>HIV infected children</keyword>
</DOC>